Delivery Order SPE2DB24D1034-SPE2DB24FWCM9
Award Date
9/12/24
Potential Completion Date
9/13/24
Potential Value
$4.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Cosentyx 300 mg dose-2 pens to the Defense Logistics Agency (DLA). The $3,136.32 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a period of performance through May 25, 2023. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is for Cosentyx 300 mg dose-2 pen, a specialty pharmaceutical product, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $9,131.76 with a firm fixed price structure and a completion date of February 22, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of Cosentyx (secukinumab) 300 mg dosage injectable medication. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, and does not have a set-aside designation. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $4,680.45, and has an ultimate completion date of September 20, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation is for the delivery of Cosentyx (secukinumab) 300mg dosage pharmaceutical products. The $1,607 firm-fixed-price delivery order has a completion date of July 18, 2024 and does not utilize a set-aside. AmerisourceBergen is the prime contractor and holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for the company to...
This federal contract award is for the delivery of Cosentyx (secukinumab) 300mg dose prefilled syringes to the Defense Logistics Agency (DLA), a component of the Department of Defense. The $12,637.98 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 2, 2024. The contract has a completion date of December 3, 2024 and was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of Cosentyx (secukinumab) 300mg dose syringes to the Defense Logistics Agency (DLA). The $11,139.37 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, through the company's Indefinite Delivery Contract (IDC) with the DLA valued at $999,999,999. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military...
This federal contract award is for the delivery of Cosentyx Unoready 300 mg pen injectors to the Defense Logistics Agency (DLA) Troop Support Medical. The $7,837.91 firm fixed price contract was awarded to prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 17, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $15,258.91, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Cosentyx (secukinumab) 300mg doses, a specialty medication used to treat certain autoimmune conditions. The contract is a Firm Fixed Price Delivery Order with a completion date of July 18, 2024. There is no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Cosentyx (secukinumab) 300 mg dosage pens, a specialty medication used for various medical conditions. The contract has a ceiling value of $21,495.87 and runs through June 27, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,350.74, is for the delivery of Cosentyx (Secukinumab) 300 mg Pen injectors. This is a Firm Fixed Price Delivery Order contract with a completion date of December 11, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...